TrialPloS one2025

Pre-treatment subjective sleep quality as a predictive biomarker of tDCS effects in preclinical Alzheimer's disease patients: Secondary analysis of a randomised clinical trial.

Hanna Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.